Brain activity and nerve health study in Lewy body disease
Part of Brain & nervous system, Mental health clinical trials.
This trial looks at brain wave patterns (EEG) and nerve damage in people with Lewy body disease. It uses past data from a study called Alpha-Lewy-MA and a special test (RT-QuIC) to learn more about the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You took part in the Alpha-Lewy-MA research study before.
- Your sample was tested with the RT-QuIC method as part of that study.
- You had a standard EEG brain wave test at the University Hospital of Strasbourg between January 1, 2012 and January 1, 2020.
- You have not said you do not want to be in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain function changes over time in people with Lewy body disease or Alzheimer's. Researchers will use memory tests, MRI scans, and EEG (a painless brain-wave recording) to track these changes, and you will need a family member or friend to help report on your daily life.
This trial follows people with probable Lewy body dementia over several years to see how the brain changes on MRI and on memory/thinking tests. It may help researchers understand disease progression and improve future care for Lewy body dementia.
This study helps people understand a protein called alpha-synuclein that may be related to memory problems and movement disorders. Researchers will either test your spinal fluid or skin to look for this protein, then discuss the results with you and measure how you're doing over time.
This early-stage study tests whether ambroxol can act as a “disease-modifying” treatment for Lewy body dementia, meaning it aims to change how the illness progresses rather than only relieve symptoms. You may be asked to complete brain testing and have stable medications while the study monitors memory, thinking, and safety.
This study tests digital health tools (like sensors or apps) to track symptoms of progressive supranuclear palsy (PSP) or dementia with Lewy bodies (DLB) at home. It may help researchers understand how these conditions progress and improve care.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
Hear when a new Lewy Body Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.